Managing Global Biomarker Operations Across Borders: Navigating Country-Specific Regulations & Geopolitical Complexity at Scale
4:15 pm - Monday 16th November 2026
- Aligning issue escalation and operational governance across globally distributed teams to keep sample delivery consistent regardless of region
- Navigating country-specific regulatory challenges, including China’s HGRAC requirements and the US PROTECT Act, to keep global trials moving without costly delays
- Building a collaborative operating model with central lab providers that anticipates geopolitical and regulatory shifts, rather than reacting to them after they derail a trial
